IDH.L Regulatory News (IDH)

Annual Report and AGM

14 July 2014

Immunodiagnostic Systems Holdings PLC

("IDS", "Company" or "Group")

2014 Annual Report & Accounts and Notice of Annual General Meeting

IDS, a leading producer of manual and automated specialist diagnostic testing kits and instrumentation for the clinical and research markets, confirms that it has published its Annual Report & Accounts for the year ended 31 March 2014. The document has been posted to shareholders and is available from the Company's website: www.idsplc.com.

IDS confirms that its 2014 Annual General Meeting will be held at 2.00pm on Monday 4 August 2014 at its registered office at 10 Didcot Way, Boldon Business Park, Boldon, Tyne & Wear NE35 9PD. The AGM Notice has been posted with the Annual Report & Accounts to shareholders and is available on the Company's website.

For further information:

 About Immunodiagnostic Systems Holdings PLC:

The Group's vision is to be a leading solution provider to the clinical laboratory diagnostic market. IDS's strategy is focused on developing, internally and through partnership, its automated assay menu for its proprietary automated immunoassay analyser, the IDS-iSYS system. Internally the Group is focused on developing an endocrinology excellence menu and externally IDS works with partners to develop assay panels in complementary indication fields. The Group sells its products primarily in the clinical laboratory market across a range of customers from reference laboratories to physician office laboratories. IDS has field sales forces in certain European countries, including France and Germany, the United States and Brazil and works with distributors in other markets including China, Italy and Spain.

 http://www.idsplc.com